Dimensional Fund Advisors LP Ligand Pharmaceuticals Inc Transaction History
Dimensional Fund Advisors LP
- $376 Billion
- Q2 2024
A detailed history of Dimensional Fund Advisors LP transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 708,624 shares of LGND stock, worth $74.2 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
708,624
Previous 664,081
6.71%
Holding current value
$74.2 Million
Previous $48.5 Million
23.0%
% of portfolio
0.02%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding LGND
# of Institutions
247Shares Held
17.5MCall Options Held
61KPut Options Held
7.8K-
Black Rock Inc. New York, NY2.87MShares$301 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.93MShares$202 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.01MShares$106 Million0.05% of portfolio
-
Macquarie Group LTD Australia, C3967KShares$101 Million0.1% of portfolio
-
State Street Corp Boston, MA689KShares$72.2 Million0.0% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $1.77B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...